Belgium vs Israel: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Belgium
94.0%
in 2024
Israel
94.0%
in 2024
Belgium rank
34th
Israel rank
34th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Belgium
- Israel
How they compare
Belgium currently reports 94.0% against 94.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was Israel ahead.
Belgium ranks 34th and Israel ranks 34th of 146 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.6% | 94.0% | 0.4% | Israel |
| 2020s | 94.0% | 94.2% | 0.2% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Belgium or Israel?
- Belgium, at 94.0% against 94.0% in Israel as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Belgium and Israel?
- 0.0%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Israel?
- 13 years are reported by both, from 2012 to 2024.
- How do Belgium and Israel rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Belgium ranks 34th and Israel ranks 34th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.